Steris (STE) Cost of Revenue (2018 - 2026)

Steris' Cost of Revenue history runs 9 years deep, the most recent figure standing at $891.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 6.17% year-over-year to $891.2 million; the TTM figure through Mar 2026 stood at $3.3 billion (up 8.26% YoY), while the FY2026 annual figure was $3.3 billion, up 8.26% from the prior year.
• Cost of Revenue was $891.2 million for Q1 2026 at Steris, up from $840.7 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $891.2 million in Q1 2026 to a low of $577.8 million in Q2 2022.
• Historically, Cost of Revenue has averaged $734.2 million across 5 years, with a median of $737.7 million in 2023.
• Biggest YoY gain for Cost of Revenue was 29.44% in 2022; the steepest drop was 15.07% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $634.2 million in 2022, then gained by 16.31% to $737.7 million in 2023, then rose by 3.05% to $760.2 million in 2024, then increased by 10.59% to $840.7 million in 2025, then climbed by 6.01% to $891.2 million in 2026.
• The last three Cost of Revenue figures came in at $891.2 million (Q1 2026), $840.7 million (Q4 2025), and $814.4 million (Q3 2025), per Business Quant data.